Case File
efta-efta00690528DOJ Data Set 9OtherFrom: "Paul V. Morris"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00690528
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Paul V. Morris"
To: Jeffrey Epstein <[email protected]>
Subject: The Weekly Letter: The New Geopolitical Normal
Date: Tue, 25 Oct 2016 14:39:35 +0000
>
laCIO Weekly
The New Geopolitical
Normal
The geopolitical backdrop has never been messier. Of
notable concern: surging Chinese military spending that
portends rising military expenditures across the region.
Beneficiaries of this dynamic will include many large
U.S. defense contractors that count numerous Asian states
as clients. We reiterate one of our high-conviction
investment themes of being long U.S. defense companies,
despite current lofty valuations. Rising geopolitical risks
should remain a significant revenue tailwind for the
sector over the medium term.
Find out more in the new edition of The Weekly Letter,
The New Geopolitical Normal.
We also encourage you to visit ml.com/insights for our
latest thinking on long-term investment themes, including
seven recently published articles, as well as our midyear
updates on the markets and the economy.
The Morris Group
Private Wealth Manager
Read the latest CIO Weekly
The Morris Group
Managing Director-Wealth
Management
Private Wealth Manager
One Bryant Park, 28th Floor
New York, NY 10036
(212) 680-5919
EFTA00690528
Some of the risks involved with equities include the possibility that the value of the stocks may fluctuate in
response to events specific to the companies or markets, as well as economic, political or social events in the
U.S. or abroad.
Bonds are subject to interest rate, inflation and credit risks. Investments in high-yield bonds may be subject to
greater market fluctuations and risk of loss of income and principal than securities in higher rated categories.
There are special risks associated with an investment in commodities, including market price fluctuations,
regulatory changes, interest rate changes, credit risk, economic changes and the impact of adverse political or
financial factors.
The investments or strategies presented do not take into account the investment objectives or financial needs of
particular investors. It is important that you consider this information in the context of your personal risk
tolerance and investment goals before making an investment decision.
Merrill Lynch makes available products and services offered by Merrill Lynch, Pierce, Fenner & Smith Incorporated
(MLPF&S) and other subsidiaries of Bank of America Corporation. (BofA Corp.).
The Private Banking and Investment Group is a division of Merrill Lynch, Pierce, Fenner & Smith Incorporated that offers a
broad array of personalized wealth management products and services. Both brokerage and investment advisory services
(including financial planning) are offered by the Group's Private Wealth Advisors through MLPF&S. The nature and degree
of advice and assistance provided, the fees charged, and client rights and Merrill Lynch's obligations will differ among
these services.
The banking, credit and trust services sold by the Group's Private Wealth Advisors are offered by licensed banks and trust
companies, including Bank of America, N.A., Member FDIC, and other affiliated banks.
Investments involve risk, including the possible loss of principal investment. Past performance is no guarantee of
future results.
Investment products:
Are Not FDIC Insured
Are Not Bank Guaranteed
May Lose Value
MLPF&S is a registered broker-dealer, Member SIPC and a wholly owned subsidiary of Bank of America Corporation.
@ 2016 Bank of America Corporation. All rights reserved.
ARPSHSNS
If
prefer not to receive future e-mails related to this topic click here
EFTA00690529
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.